Biogened SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biogened SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014105
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BIOGENED SA (Biogened) is a drug company that develops, produces, and distributes Rx medicines and dietary supplements. The company’s products include recipes dermocosmetic products, specialized products, active ingredients, pharmaceutical products, and cosmetic products. Its also offers novelties, dermatological, neurological, psychiatric, dietary supplements, and natural cosmetic products. Biogened also provides skin diagnosis products, skin care products, cleansing products, antiperspirant body care products, sunlight protection products, and anti ageing products, among others. The company offers services such as research and development, drug discovery, quality management, and warehousing services. It offers its products and services to pharmaceutical company and researchers. Biogened is headquartered in Lodz, Poland.

Biogened SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biogened SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biogened SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biogened SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biogened SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biogened SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biogened SA, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Biogened Plans to Raise Funds through Private Placement of Shares 10
Biogened Raises USD1.8 Million in Private Placement of Shares 11
Biogened Completes Private Placement Of Shares For US$0.03 Million 12
Biogened SA – Key Competitors 13
Biogened SA – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Biogened SA, Pharmaceuticals & Healthcare, Key Facts 2
Biogened SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biogened SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biogened SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biogened SA, Deals By Therapy Area, 2011 to YTD 2017 8
Biogened SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biogened Plans to Raise Funds through Private Placement of Shares 10
Biogened Raises USD1.8 Million in Private Placement of Shares 11
Biogened Completes Private Placement Of Shares For US$0.03 Million 12
Biogened SA, Key Competitors 13

★海外企業調査レポート[Biogened SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Foxconn Technology Co Ltd
    Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Foxconn Technology Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DNAtrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Goa Shipyard Ltd:企業の戦略・SWOT・財務分析
    Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report Summary Goa Shipyard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Novadaq Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Novadaq Technologies Inc (Novadaq) is a medical imaging company. It develops, manufactures and markets real-time fluorescence imaging technology products. The company’s SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging sy …
  • Sotheby’s (BID):企業の財務・戦略的SWOT分析
    Sotheby's (BID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Telephonics Corp:企業の戦略的SWOT分析
    Telephonics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Shikoku Electric Power Co Inc (9507):企業の財務・戦略的SWOT分析
    Shikoku Electric Power Co Inc (9507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Riken Vitamin Co Ltd:企業の戦略・SWOT・財務情報
    Riken Vitamin Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Riken Vitamin Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corporation (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sibur Holding:企業の戦略的SWOT分析
    Sibur Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務情報
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務情報
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Direct Energy Marketing Ltd:企業の戦略的SWOT分析
    Direct Energy Marketing Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Catholic University of Leuven:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic University of Leuven (KU Leuven) is a scientific research and educational service provider that provides bachelors degree, post graduate degree and doctorate degree programs. The university provides educational courses in the areas of psychology and educational sciences, arts, law, …
  • Liberty House Group:企業の戦略・SWOT・財務情報
    Liberty House Group - Strategy, SWOT and Corporate Finance Report Summary Liberty House Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Charter Hall Group:企業のM&A・事業提携・投資動向
    Charter Hall Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charter Hall Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Safe Orthopaedics SA (SAFOR):企業の製品パイプライン分析2018
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆